Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Total Debt
Short-term and long-term borrowings combined.
Beta Bionics, Inc.NASDAQ: BBNX
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt broadly unchanged from a year ago
Total debt stood at $6.91M at the end of Q1 FY2026, down 0.9% from a year earlier and down 5.4% from the prior quarter. Over 3 fiscal years it compounded at +20.9% a year.
Context
- Total debt amounted to 2.3% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Total debt increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -0.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 7.3M USD
- Year-over-year change
- +0.7%
- 3-year CAGR
- +20.9%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.3M | +0.7% |
| FY2024 | 2024-12-31 | 7.26M | +71.8% |
| FY2023 | 2023-12-31 | 4.22M | +2.2% |
| FY2022 | 2022-12-31 | 4.13M | — |
Total Debt vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -0.9% is the 5th highest of 7, against a peer median of +45.1%.
- Total debt amounts to 2.3% of total assets for BBNX, versus a peer median of 23.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 140.13B DKK | +41.2% | +71.9% | 23.6% | |
| Jun 2026 | $1.4B USD | -45.8% | -13.5% | 21.7% | |
| Jun 2026 | $948.4M USD | -33.1% | -9.8% | 30.0% | |
| Mar 2026 | $734.74M USD | +49.0% | +1.9% | 63.7% | |
| Mar 2026 | $436.67M USD | +824.2% | +18.0% | 58.7% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $59M USD | — | — | 1.3% |
| Mar 2026 | $6.91M USD | -0.9% | +20.9% | 2.3% | |
| Mar 2026 | $761K USD | +152.8% | -2.6% | 0.3% | |
| Peer median (excluding BBNX) | — | +45.1% | -0.4% | 23.6% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.